Ariad Pharmaceuticals Inc. (ARIA)


Ariad Pharmaceuticals Inc. discovers and develops medicines to treat cancer by regulating cell signaling with small molecules. The company is developing a comprehensive approach to the treatment of cancer and is primarily focused on a series of product candidates for targeted indications.

View SEC Filings from ARIA instead.
Filers who had this stock in their top 10: 6
13F Filers holding this stock: 181
Aggregate shares on 06/30/2016: 138,751,168
Aggregate shares on 03/31/2016: 135,301,415
Percent change: 2.55%
Funds creating new positions: 40
Funds Adding to an existing position: 65
Funds closing out their position: 20
Funds reducing their position: 45
View recent insider trading info

13F Filers holding this stock

Quarter 1: Refresh

Changes in Holdings:

*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Schedule 13D and 13G filings submitted since 06/30/2016

Subscription required

Click here to report any possible errors with this stock listing.

Elevate your investments

or Learn more